T. Rowe Price Investment Management, Inc. Applied Therapeutics Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $162 Billion
- Q4 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 5,420,920 shares of APLT stock, worth $3.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,420,920
Previous 207,550
2511.86%
Holding current value
$3.2 Million
Previous $1.77 Million
163.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding APLT
# of Institutions
130Shares Held
112MCall Options Held
1.1MPut Options Held
800K-
Vestal Point Capital, LP New York, NY11.5MShares$6.79 Million0.58% of portfolio
-
Vr Adviser, LLC New York, NY9.99MShares$5.89 Million1.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA9.62MShares$5.67 Million8.18% of portfolio
-
Morgan Stanley New York, NY8.82MShares$5.2 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.76MShares$5.17 Million0.05% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $28.3M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...